Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
Overall
Abstract
The Center for Solutions for ME/CFS (CfS for ME/CFS) is an inter-disciplinary, inter-institutional center
comprised of clinicians, clinical investigators, basic scientists who are committing to working together to
understand the pathogenesis of ME/CFS and develop evidence-based strategies for interventions that prevent
and mitigate disease. The team initially coalesced with an NIH call to respond to spurious reports linking
xenotropic murine leukemia virus-related virus (XMRV) to ME/CFS. It consolidated its vision with support from
the Hutchins Family Foundation Chronic Fatigue Initiative (CFI) and a crowd-funding organization, The Microbe
Discovery Project, to explore the role of infection and immunity in disease and identify biomarkers for diagnosis
through functional genomic, proteomic, and metabolomic discovery. The foundation for this project is a large
clinical database and sample repository representing oral, fecal, and blood samples from well-characterized
ME/CFS subjects and frequency-matched controls collected nationwide over a period of several years. In
Project 1, we survey for the presence of molecular footprints of bacterial, fungal, and viral agents and
corresponding immune responses in a 100 case/100 control subset of repository samples using high
throughput sequencing, high density peptide arrays, and immune signature assays; this Project also examines
the prevalence of autoantibodies selected based on clinical and literature reports. In Project 2, we profile the
plasma metabolome and PBMC transcriptome in the same subjects studied in Project 1 using state-of-the-art
mass spectrometric and RNA-seq methods, comprehensive mass spectral libraries, and tools for RNA profiling
in bulk cell populations using cell sub-type specific markers. We also pursue metabolomic and transcriptomic
analyses after orthostatic and exercise challenges using samples collected in Project 3. In Project 3, we mine
existing databases at Columbia and the CFI for insights into clinical features, comorbidities, and sub-types that
can be used to refine laboratory analyses, as well as enhance patient care. We will work with clinicians and the
ME/CFS community to design a mobile app that will allow patients and caregivers to track clinical status in
response to stressors and interventions, and will provide prospective research data. We will also investigate
the utility of the Lean Test as a simple outpatient test for autonomic function.
Public Health Relevance Statement
Overall
Narrative
The Center for Solutions for ME/CFS is a multi-institutional, inter-disciplinary research center dedicated to
understanding the biology of ME/CFS and developing diagnostic tests and methods for preventing and treating
disease. It builds on decades of work by a network of expert clinicians and laboratory scientists with expertise
in epidemiology, infectious disease, immunology, genetics and biochemistry, as well as a large cohort of well-
characterized patients and biological samples. Our efforts will be linked with those of other Collaborative
Research Centers and guided by close interactions with the ME/CFS community.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AbbreviationsAdvisory CommitteesAlgorithmsAnalytical ChemistryAutoantibodiesBasic ScienceBiochemistryBiologicalBiological AssayBiological MarkersBiologyBlood specimenCaregiversCellsCenters for Disease Control and Prevention (U.S.)Chemical StructureChronicChronic Fatigue SyndromeClinicalClinical InvestigatorCollectionCommunitiesComorbidityComplexConsultationsCrowdingDataData ScientistDatabasesDiagnosisDiagnosticDiagnostic ProcedureDiagnostic testsDiseaseEdible PlantsEmerging Communicable DiseasesEnsureEpidemiologistEpidemiologyEpigenetic ProcessEtiologyExerciseExercise ToleranceExercise stress testExpression ProfilingFamilyFatigueFibromyalgiaFlavonoidsFoundationsFrequenciesFundingGene ExpressionGeneticGenomicsHigh-Throughput Nucleotide SequencingImmuneImmune responseImmunityInfectionInfectious Disease ImmunologyInterdisciplinary StudyInternationalInterventionIntramural Research ProgramInvestigationInvestmentsLaboratoriesLaboratory ScientistsLeadLesionLibrariesLinkLipidsLiteratureMetabolic PathwayMethodsMicrobeMicrobiologyMiningMolecularMurine leukemia virusNational Institute of Neurological Disorders and StrokeNorth AmericaOralOutpatientsPathogenesisPatient CarePatientsPeptidesPeripheral Blood Mononuclear CellPhenotypePhysiciansPlasmaPopulationPositioning AttributePrevalenceProceduresProteomicsRNAReportingResearchResearch PersonnelResearch Project GrantsResourcesRiskRoleSamplingScientistSecuritySerologicalSourceStandardizationStudy SubjectSurveysSystems BiologyTestingThinnessTranslational ResearchUnited States National Institutes of HealthUniversitiesViralVirusVisionWorkbasebiodefensebiomarker discoverycheminformaticsclinical databasecohortcomputerized data processingcrowdsourcingdata managementdensitydesigneducation researchevidence baseflexibilityfunctional genomicsholistic approachinsightinstrumentinter-institutionalmembermetabolomemetabolomicsmicrobialmicrobiomemobile applicationpolyphenolpressurepreventprogramsprospectiverepositoryresponsestressortooltranscriptometranscriptome sequencingtranscriptomics
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
22-September-2017
Project End Date
31-August-2022
Budget Start Date
01-September-2019
Budget End Date
31-August-2020
Project Funding Information for 2019
Total Funding
$2,241,807
Direct Costs
$2,329,293
Indirect Costs
$864,566
Year
Funding IC
FY Total Cost by IC
2019
National Institute of Allergy and Infectious Diseases
$2,241,807
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U54AI138370-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U54AI138370-03
Patents
No Patents information available for 5U54AI138370-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U54AI138370-03
Clinical Studies
No Clinical Studies information available for 5U54AI138370-03
News and More
Related News Releases
No news release information available for 5U54AI138370-03
History
No Historical information available for 5U54AI138370-03
Similar Projects
No Similar Projects information available for 5U54AI138370-03